Eureka Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Eureka Therapeutics's estimated annual revenue is currently $4.2M per year.
- Eureka Therapeutics received $60.0M in venture funding in January 2018.
- Eureka Therapeutics's estimated revenue per employee is $77,500
- Eureka Therapeutics's total funding is $128.9M.
Employee Data
- Eureka Therapeutics has 54 Employees.
- Eureka Therapeutics grew their employee count by -2% last year.
Eureka Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | VP, Drug Discovery | Reveal Email/Phone |
3 | Head Finance/Corporate Controller | Reveal Email/Phone |
4 | VP, Clinical Development and Technical Operations | Reveal Email/Phone |
5 | Associate Director, Tax and FP&A | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | Director Analytics | Reveal Email/Phone |
8 | Associate Director, Investor Relations & Strategic Alliances | Reveal Email/Phone |
9 | Associate Director, process development | Reveal Email/Phone |
10 | Director Quailty | Reveal Email/Phone |
Eureka Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Eureka Therapeutics?
Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area, focused on breakthrough immunotherapies for the treatment of cancer. Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pipeline of innovative drugs, with the most advanced candidates at pre-clinical stage. Eureka Therapeutics is a leader in the discovery of novel antibody immunotherapies. We utilize a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. In collaboration with Memorial Sloan-Kettering Cancer Center, we were the first-to-demonstrate in vivo efficacy of a human IgG1 antibody against an intracellular cancer antigen. Our most advanced program is at preclinical stage and being developed in partnership with Novartis.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
$128.9M
Total Funding
54
Number of Employees
$4.2M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Eureka Therapeutics News
Alnylam Pharmaceuticals Inc., AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., Eureka Therapeutics,...
Eureka Therapeutics, Inc. is a privately held clinical-stage biotechnology company focused on developing novel T cell therapies to treat cancers...
Eureka Therapeutics, a developer of T-cell therapies for solid tumors, has announced the closing of a $45 million Series E led by Lyell Immunopharma, with participation from new and existing backers. Founded in 2006 and based in Emeryville, Calif., the biotech startup will use the funds in part ...
Rivet has raised $8.25M; ZeroNorth closed $10M; Eureka Therapeutics landed $45M LumenAd: LumenAd is a management platform. LumenAd has raised $2 million in seed funding led by Next Frontier Capital. Read more Fiscozen: Fiscozen is a digital platform for managing small businesses and freelancer ...
Eureka Therapeutics, Inc., an Emeryville, Calif.-based clinical stage biotechnology company developing novel T cell therapies for solid tumors, closed a $45m Series E financing. The round was led by Lyell Immunopharma and joined by a syndicate of new and prior investors. In addition to the fina ...
Other Companies in Emeryville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7M | 54 | 6% | N/A |
#2 | $4.2M | 54 | -19% | $20.5M |
#3 | $7.5M | 57 | -20% | N/A |
#4 | $7.2M | 57 | 2% | N/A |
#5 | $8.6M | 58 | 9% | N/A |
Eureka Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-01-23 | $60.0M | D | Acorn Pacific Ventures | Article |